Translating the Science of Environmental Exposure into
Solutions for Human Health
Call for Volunteers
e-mail: hello@ecoterahealth.com
or
Scroll Down for More Info
ecotera health develops translational biotechnology and AI platforms to measure how environmental exposures—including microplastics and nanoplastics—interact with biological systems, enabling diagnostics, therapeutic development, and scalable clinical monitoring.
Interested in Volunteering for Urine Product Development?
Early research and product development (non-clinical)
-
Simple at-home sample collection
-
One-time participation (prototype testing only)
-
Fully anonymized, no personal data collected
Email hello@ecoterahealth.com
to express interest.
From Environmental Exposure to Clinical Action
Core Technology Platforms
Integrated biomedical platforms bridging environmental exposure science and human health diagnostics.
Advanced Diagnostics
Smartphone-based and laboratory-integrated systems for detection of environmental exposures in biological samples (e.g. urine and blood) for population studies or routine clinical use.
Status: Prototype validated (TRL 4–6)
Precision Therapeutics Developed by Cythera Bio
Multi-mechanism therapeutic candidates targeting exposure-associated diseases including neurodegeneration and cardiovascular conditions.
Therapeutic programs are developed through affiliated platforms, including Cythera Bio.
Status: Drug candidates supported by wet lab data, including ex vivo systems demonstrating measurable changes in particle–biological interactions in the presence of live microbial consortia. Early preclinical development.
AI + Systems Platform
Multi-model AI systems for exposure–biology interaction mapping, diagnostics, candidate discovery, and closed-loop monitoring.
Status: Active development with experimental validation